Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 853400-76-7
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of trofinetide during breastfeeding. If trofinetide is required by the mother, it is not a reason to discontinue breastfeeding. Until more data are available, trofinetide should be used with careful infant monitoring for diarrhea and proper weight gain.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Trofinetide
CAS Registry Number
853400-76-7
Drug Class
Breast Feeding
Lactation
Milk, Human
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need.[J Clin Med. 2023]Review Trofinetide for Rett Syndrome: Highlights on the Development and Related Inventions of the First USFDA-Approved Treatment for Rare Pediatric Unmet Medical Need.Hudu SA, Elmigdadi F, Qtaitat AA, Almehmadi M, Alsaiari AA, Allahyani M, Aljuaid A, Salih M, Alghamdi A, Alrofaidi MA, et al. J Clin Med. 2023 Aug 4; 12(15). Epub 2023 Aug 4.
- Review Exenatide.[Drugs and Lactation Database (...]Review Exenatide.. Drugs and Lactation Database (LactMed®). 2006
- NNZ-2566, a glypromate analog, attenuates brain ischemia-induced non-convulsive seizures in rats.[J Cereb Blood Flow Metab. 2009]NNZ-2566, a glypromate analog, attenuates brain ischemia-induced non-convulsive seizures in rats.Lu XC, Si Y, Williams AJ, Hartings JA, Gryder D, Tortella FC. J Cereb Blood Flow Metab. 2009 Dec; 29(12):1924-32. Epub 2009 Jul 29.
- A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome.[Pediatr Neurol. 2020]A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome.Berry-Kravis E, Horrigan JP, Tartaglia N, Hagerman R, Kolevzon A, Erickson CA, Hatti S, Snape M, Yaroshinsky A, Stoms G, et al. Pediatr Neurol. 2020 Sep; 110:30-41. Epub 2020 May 23.
- Review Zuranolone.[Drugs and Lactation Database (...]Review Zuranolone.. Drugs and Lactation Database (LactMed®). 2006
- Trofinetide - Drugs and Lactation Database (LactMed®)Trofinetide - Drugs and Lactation Database (LactMed®)
- eggc.vippip (0)BioProject
- eggc.vipScO (0)BioProject
Your browsing activity is empty.
Activity recording is turned off.
See more...